Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from ASKA Pharmaceutical Holdings Co., Ltd. ( (JP:4886) ) is now available.
ASKA Pharmaceutical Holdings Co., Ltd. has revised its consolidated financial forecasts for FY2025, lowering its net sales and profit expectations due to a change in sales recording methods and increased R&D expenses. The revision reflects a strategic shift in accounting practices and a focus on enhancing drug discovery capabilities, which may impact the company’s financial performance and stakeholder expectations.
The most recent analyst rating on (JP:4886) stock is a Hold with a Yen2305.00 price target. To see the full list of analyst forecasts on ASKA Pharmaceutical Holdings Co., Ltd. stock, see the JP:4886 Stock Forecast page.
More about ASKA Pharmaceutical Holdings Co., Ltd.
ASKA Pharmaceutical Holdings Co., Ltd. operates in the pharmaceutical industry, focusing on the development and distribution of pharmaceutical products. The company is involved in drug discovery and aims to expand its pipeline for future growth.
Average Trading Volume: 75,832
Technical Sentiment Signal: Sell
Current Market Cap: Yen55.73B
See more data about 4886 stock on TipRanks’ Stock Analysis page.